Literature DB >> 10936612

Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs.

C Song1, R A Hiipakka, S Liao.   

Abstract

We have found that certain natural 6alpha-hydroxylated bile acids are receptor-specific activators of nuclear liver X receptor alpha (LXRalpha) (NR1H3), a nuclear receptor regulating the expression of the cholesterol 7alpha-hydroxylase gene, coding for the rate-limiting enzyme in the major pathway of bile acid synthesis. The LXR homolog, ubiquitous nuclear receptor (UR/LXRbeta) (NR1H2), was also activated by these bile acids, but at higher concentrations than for LXRalpha. Synthetic 6alpha-hydroxylated bile acid analogs were synthesized with LXRalpha-selective agonistic activity, with potential to modulate cholesterol catabolism in hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936612     DOI: 10.1016/s0039-128x(00)00127-6

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  23 in total

Review 1.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

Review 2.  Role of Liver X Receptor in Mastitis Therapy and Regulation of Milk Fat Synthesis.

Authors:  Xiaoyu Hu; Naisheng Zhang; Yunhe Fu
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-31       Impact factor: 2.673

3.  Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice.

Authors:  Peizhen Song; Youcai Zhang; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2011-07-11       Impact factor: 4.849

4.  Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis.

Authors:  Spyridon Theofilopoulos; Yuqin Wang; Satish Srinivas Kitambi; Paola Sacchetti; Kyle M Sousa; Karl Bodin; Jayne Kirk; Carmen Saltó; Magnus Gustafsson; Enrique M Toledo; Kersti Karu; Jan-Åke Gustafsson; Knut R Steffensen; Patrik Ernfors; Jan Sjövall; William J Griffiths; Ernest Arenas
Journal:  Nat Chem Biol       Date:  2012-12-23       Impact factor: 15.040

5.  GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis.

Authors:  Simona De Marino; Claudia Finamore; Michele Biagioli; Adriana Carino; Silvia Marchianò; Rosalinda Roselli; Cristina Di Giorgio; Martina Bordoni; Francesco Saverio Di Leva; Ettore Novellino; Chiara Cassiano; Vittorio Limongelli; Angela Zampella; Carmen Festa; Stefano Fiorucci
Journal:  ACS Med Chem Lett       Date:  2020-03-02       Impact factor: 4.345

Review 6.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12

Review 7.  Diet, fatty acids, and regulation of genes important for heart disease.

Authors:  John P Vanden Heuvel
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

8.  Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe).

Authors:  Karianne Solaas; Vanessa Legry; Kjetil Retterstol; Paul R Berg; Kirsten B Holven; Jean Ferrières; Philippe Amouyel; Sigbjorn Lien; Javier Romeo; Jara Valtueña; Kurt Widhalm; Jonatan R Ruiz; Jean Dallongeville; Serena Tonstad; Helge Rootwelt; Bente Halvorsen; Marit S Nenseter; Kare I Birkeland; Per M Thorsby; Aline Meirhaeghe; Hilde I Nebb
Journal:  BMC Med Genet       Date:  2010-10-12       Impact factor: 2.103

Review 9.  Novel insight into mechanisms of cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

Review 10.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.